You will not be routed through the Bridge if you have any of these conditions: Type 2 diabetes Ozempic, Mounjaro, and other GLP-1s are covered under standard Part D for T2D
A trial for tirzepatide included results for the drugs lowest dose, which is considered the starting therapeutic maintenance dose after titration, and shows substantial efficacy
Weeks 14: 0.25 mg once a week Weeks 58: 0.5 mg Weeks 912: 1 mg Weeks 1316: 1.7 mg (if needed) Week 17 and beyond: 2.4 mg (maintenance) Weeks 14: 2.5 mg weekly (starting dose) Week 5+: 5 mg weekly Increase by 2.5 mg every 4 weeks if needed Maximum: 15 mg weekly Your provider will help you determine the right pace based on how youre responding
The cumulative incidence was 6.7% for GLP-1 compared to 0.8% for non-GLP-1 RA over 36 months, with a hazard ratio (HR) of 7.64 (95% CI, 2.21-26.36
Tools for precision For safe microdosing, follow this practice: If you are using multidose vials, consider using insulin syringes or small-volume syringes to draw precise small amounts of the medication
The Journal of Clinical Investigation, 110, 4352
